tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
J&J weighs sale of DePuy amid private equity interest, Bloomberg says
PremiumThe FlyJ&J weighs sale of DePuy amid private equity interest, Bloomberg says
4d ago
Johnson & Johnson preparing for sale of orthopedics unit, Bloomberg says
Premium
The Fly
Johnson & Johnson preparing for sale of orthopedics unit, Bloomberg says
4d ago
FDA to begin requiring on clinical trial
Premium
The Fly
FDA to begin requiring on clinical trial
5d ago
Johnson & Johnson granted BTD for RYBREVANT FASPRO from FDA
PremiumThe FlyJohnson & Johnson granted BTD for RYBREVANT FASPRO from FDA
5d ago
Genmab sees 2026 revenue $4.065B-$4.395B, consensus $4.13B
Premium
The Fly
Genmab sees 2026 revenue $4.065B-$4.395B, consensus $4.13B
6d ago
Johnson & Johnson’s Rybrevant Faspro regimen approved by FDA for NSCLC
Premium
The Fly
Johnson & Johnson’s Rybrevant Faspro regimen approved by FDA for NSCLC
6d ago
Trump Trade: Argentina says U.S. to cut hundreds of tariffs
PremiumThe FlyTrump Trade: Argentina says U.S. to cut hundreds of tariffs
17d ago
TrumpRx website using technology from GoodRx, STAT says
Premium
The Fly
TrumpRx website using technology from GoodRx, STAT says
18d ago
Johnson & Johnson price target raised to $255 from $240 at RBC Capital
Premium
The Fly
Johnson & Johnson price target raised to $255 from $240 at RBC Capital
20d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100